The Role of Polo-like Kinase 1 in Carcinogenesis: Cause or Consequence?CHOLEWA, Brian D; XIAOQI LIU; AHMAD, Nihal et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 23, pp 6848-6855, issn 0008-5472, 8 p.Article

Phosphorylation of TCTP as a Marker for Polo-like Kinase-1 Activity In VivoCUCCHI, Ulisse; GIANELLINI, Laura M; GIORGINI, Maria L et al.Anticancer research. 2010, Vol 30, Num 12, pp 4973-4985, issn 0250-7005, 13 p.Article

Polo-like kinase 1 phosphorylates and regulates Bcl-x_L during pironetin-induced apoptosisTAMURA, Y; SIMIZU, S; MUROI, M et al.Oncogene (Basingstoke). 2009, Vol 28, Num 1, pp 107-116, issn 0950-9232, 10 p.Article

Tumor regression by combination antisense therapy against Plk1 and Bcl-2ELEZ, Robert; PIIPER, Albrecht; KRONENBERGER, Bernd et al.Oncogene (Basingstoke). 2003, Vol 22, Num 1, pp 69-80, issn 0950-9232, 12 p.Article

P21-activated kinase is required for mitotic progression and regulates Plk1MAROTO, B; YE, M. B; VON LOHNEYSEN, K et al.Oncogene (Basingstoke). 2008, Vol 27, Num 36, pp 4900-4908, issn 0950-9232, 9 p.Article

RGC32, a novel p53-inducible gene, is located on centrosomes during mitosis and results in G2/M arrestSAIGUSA, K; IMOTO, I; TANIKAWA, C et al.Oncogene (Basingstoke). 2007, Vol 26, Num 8, pp 1110-1121, issn 0950-9232, 12 p.Article

Induction of tetraploidy through loss of p53 and upregulation of Plk1 by human papillomavirus type-16 E6INCASSATI, A; PATEL, D; MCCANCE, D. J et al.Oncogene (Basingstoke). 2006, Vol 25, Num 17, pp 2444-2451, issn 0950-9232, 8 p.Article

Evaluation of Polo-like Kinase 1 inhibition on the G2/M checkpoint in Acute Myelocytic LeukaemiaDIDIER, Christine; CAVELIER, Cindy; QUARANTA, Muriel et al.European journal of pharmacology. 2008, Vol 591, Num 1-3, pp 102-105, issn 0014-2999, 4 p.Article

β-Hydroxyisovalerylshikonin induces apoptosis in human leukemia cells by inhibiting the activity of a polo-like kinase 1 (PLK1)MASUDA, Yutaka; NISHIDA, Ayano; HORI, Kouichi et al.Oncogene (Basingstoke). 2003, Vol 22, Num 7, pp 1012-1023, issn 0950-9232, 12 p.Article

Absence of tumor-specific over-expression of Polo-like kinase 1 (Plk1) in major non-Hodgkin lymphoma and relatively low expression of Plk1 in nasal NK/T cell lymphomaIMAI, Hidenori; SUGIMOTO, Koichi; ISOBE, Yasushi et al.International journal of hematology. 2009, Vol 89, Num 5, pp 673-678, issn 0925-5710, 6 p.Article

High expression levels of cyclin B1 and Polo-like kinase 1 in ectopic endometrial cells associated with abnormal cell cycle regulation of endometriosisLI TANG; WANG, Ting-Ting; WU, Yan-Ting et al.Fertility and sterility. 2009, Vol 91, Num 4, pp 979-987, issn 0015-0282, 9 p.Article

Regulation of cAMP on the First Mitotic Cell Cycle of Mouse EmbryosAIMING YU; ZHE ZHANG; QIANG BI et al.Molecular reproduction and development (Print). 2008, Vol 75, Num 3, pp 489-495, issn 1040-452X, 7 p.Article

RNAse A-like enzymes in serum inhibit the anti-neoplastic activity of siRNA targeting Polo-like kinase 1HAUPENTHAL, Jörg; BAEHR, Christina; ZEUZEM, Stefan et al.International journal of cancer. 2007, Vol 121, Num 1, pp 206-210, issn 0020-7136, 5 p.Article

Rational combinations of siRNAs targeting Plk1 with breast cancer drugsSPÄNKUCH, B; KURUNCI-CSACSKO, E; KAUFMANN, M et al.Oncogene (Basingstoke). 2007, Vol 26, Num 39, pp 5793-5807, issn 0950-9232, 15 p.Article

Polo-like kinase 1 enhances survival and mutagenesis after genotoxic stress in normal cells through cell cycle checkpoint bypassCHUN, Gina; BAE, Dongsoon; NICKENS, Kristen et al.Carcinogenesis (New York. Print). 2010, Vol 31, Num 5, pp 785-793, issn 0143-3334, 9 p.Article

Dissecting the phenotypes of Plk1 inhibition in cancer cells using novel kinase inhibitory chemical CBB2001RONGFENG LAN; GUIMIAO LIN; FEI LU et al.Laboratory investigation. 2012, Vol 92, Num 10, pp 1503-1514, issn 0023-6837, 12 p.Article

Phase I Study of GSK461364, a Specific and Competitive Polo-like Kinase 1 Inhibitor, in Patients with Advanced Solid MalignanciesOLMOS, David; BARKER, Douglas; SMITH, Deborah A et al.Clinical cancer research (Print). 2011, Vol 17, Num 10, pp 3420-3430, issn 1078-0432, 11 p.Article

Polo-Like Kinase 1 is a Therapeutic Target in High-Risk NeuroblastomaACKERMANN, Sandra; GOESER, Felix; SCHULTE, Johannes H et al.Clinical cancer research (Print). 2011, Vol 17, Num 4, pp 731-741, issn 1078-0432, 11 p.Article

Expression profiling and differential screening between hepatoblastomas and the corresponding normal livers: identification of high expression of the PLK1 oncogene as a poor-prognostic indicator of hepatoblastomasYAMADA, Shin-Ichi; OHIRA, Miki; HIYAMA, Eiso et al.Oncogene (Basingstoke). 2004, Vol 23, Num 35, pp 5901-5911, issn 0950-9232, 11 p.Article

Characterization of polo-like kinase-1 in rat oocytes and early embryos implies its functional roles in the regulation of meiotic maturation, fertilization, and cleavageFAN, Heng-Yu; CHAO TONG; TENG, Chun-Bo et al.Molecular reproduction and development (Print). 2003, Vol 65, Num 3, pp 318-329, issn 1040-452X, 12 p.Article

An Open-Label, Phase I Study of the Polo-like Kinase-1 Inhibitor, BI 2536, in Patients with Advanced Solid TumorsHOFHEINZ, Ralf-Dieter; AL-BATRAN, Salah-Eddin; HOCHHAUS, Andreas et al.Clinical cancer research (Print). 2010, Vol 16, Num 18, pp 4666-4674, issn 1078-0432, 9 p.Article

Disturbed mitotic progression and genome segregation are involved in cell transformation mediated by nano-Ti02 long-term exposureHUANG, Shing; PIN JU CHUEH; LIN, Yun-Wei et al.Toxicology and applied pharmacology. 2009, Vol 241, Num 2, pp 182-194, issn 0041-008X, 13 p.Article

Polo-like Kinase 1: A Potential Therapeutic Option in Combination with Conventional Chemotherapy for the Management of Patients with Triple-Negative Breast CancerMAIRE, Virginie; NEMATI, Fariba; GENTIEN, David et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 2, pp 813-823, issn 0008-5472, 11 p.Article

Induction of antitumor immunity using dendritic cells electroporated with Polo-like kinase 1 (Plk1) mRNA in murine tumor modelsPARK, Jung-Sun; SOHN, Hyun-Jung; PARK, Gyeong-Sin et al.Cancer science. 2011, Vol 102, Num 8, pp 1448-1454, issn 1347-9032, 7 p.Article

Inhibition of Polo-Like Kinase 1 Induces Cell Cycle Arrest and Sensitizes Glioblastoma Cells to Ionizing RadiationPEZUK, Julia Alejandra; BRASSESCO, María Sol; MORALES, Andressa Gois et al.Cancer biotherapy & radiopharmaceuticals. 2013, Vol 28, Num 7, pp 516-522, issn 1084-9785, 7 p.Article